...
The results for this analysis could be represented in tabular format as shown in the following table, where the value of the id attribute of the analysis is shown in the "analysisId" column and the groupingId and groupId values from the 2 instances of the ResultGroup class found in the resultGroups attribute for each result are represented in separate pairs of columns ("groupingId1"/"groupId1" and "groupingId2"/"groupId2") so that each result is represented on a single row:
Dataset2 |
---|
analysisId | operationId | groupingId1 | groupId1 | groupingId2 | groupId2 | rawValue | formattedValue |
---|
An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_1_n | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_1 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_1 | 33 | 33 | An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_1_n | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_1 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_2 | 53 | 53 | An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_1_n | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_2 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_1 | 34 | 34 | An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_1_n | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_2 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_2 | 50 | 50 | An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_1_n | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_3 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_1 | 44 | 4444 | An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_1_n | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_3 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_2 | 40 | 40 | An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_2_pct | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_1 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_1 | 38.3720930232558 | ( 38.4) | An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_2_pct | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_1 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_2 | 61.6279069767442 | ( 61.6) | An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_2_pct | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_2 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_1 | 40.4761904761905 | ( 40.5) | An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_2_pct | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_2 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_2 | 59.5238095238095 | ( 59.5) | An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_2_pct | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_3 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_1 | 52.3809523809524 | ( 52.4) | An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_2_pct | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_3 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_2 | 47.6190476190476 | ( 47.6) |
|
Alternatively, to aid readability, each of the identifier values could be used to retrieve and include the label (or any other descriptive information) from the definitions of the operations, grouping factors, and groups:
Dataset2 |
---|
analysisId | operationId | operation_label | groupingId1 | grouping_label1 | groupId1 | group_label1 | groupingId2 | grouping_label2 | groupId2 | group_label2 | rawValue | formattedValue |
---|
An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_1_n | n | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_1 | Placebo | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_1 | Male | 33 | 33 | An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_1_n | n | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_1 | Placebo | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_2 | Female | 53 | 53 | An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_1_n | n | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_2 | Xanomeline Low Dose | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_1 | Male | 34 | 34 | An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_1_n | n | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_2 | Xanomeline Low Dose | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_2 | Female | 50 | 50 | An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_1_n | n | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_3 | Xanomeline High Dose | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_1 | Male | 44 | 4444 | An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_1_n | n | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_3 | Xanomeline High Dose | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_2 | Female | 40 | 40 | An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_2_pct | % | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_1 | Placebo | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_1 | Male | 38.3720930232558 | ( 38.4) | An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_2_pct | % | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_1 | Placebo | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_2 | Female | 61.6279069767442 | ( 61.6) | An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_2_pct | % | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_2 | Xanomeline Low Dose | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_1 | Male | 40.4761904761905 | ( 40.5) | An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_2_pct | % | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_2 | Xanomeline Low Dose | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_2 | Female | 59.5238095238095 | ( 59.5) | An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_2_pct | % | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_3 | Xanomeline High Dose | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_1 | Male | 52.3809523809524 | ( 52.4) | An03_03_Sex_Summ_ByTrt | Mth01_CatVar_Summ_ByGrp_2_pct | % | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_3 | Xanomeline High Dose | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_2 | Female | 47.6190476190476 | ( 47.6) |
|